申请人:SUZUKI Yuichi
公开号:US20090209755A1
公开(公告)日:2009-08-20
A compound represented by the general formula:
or a pharmaceutically acceptable salt thereof or a solvate thereof, wherein Ring A is a C
6-14
aryl group or the like, L is —NR
e
CO— or the like (wherein R
e
is a hydrogen atom or the like), Ring B is a C
6-14
aryl group or the like, X is a C
1-3
alkylene group or the like, Y is a single bond or the like, Z is a C
1-3
alkylene group or the like, R
1
and R
2
are each independently a hydrogen atom or the like, and R
3
, R
4
, R
5
and R
6
are independently a hydrogen atom, a halogen atom or the like, has an Aβ production inhibitory effect or a BACE1 inhibitory effect and is useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by Aβ and typified by Alzheimer-type dementia.
一个由以下通用公式表示的化合物:或其药用可接受的盐或其溶剂化物,其中环A是C6-14芳基或类似物,L是—NReCO—或类似物(其中Re是氢原子或类似物),环B是C6-14芳基或类似物,X是C1-3烷基烯基或类似物,Y是单键或类似物,Z是C1-3烷基烯基或类似物,R1和R2各自独立地是氢原子或类似物,而R3、R4、R5和R6各自独立地是氢原子、卤原子或类似物,具有Aβ产生抑制作用或BACE1抑制作用,并且可用作由Aβ引起的以阿尔茨海默型痴呆为特征的神经退行性疾病的预防或治疗剂。